These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29672350)

  • 1. Users of a National Directory of PrEP Service Providers: Beliefs, Self-Efficacy, and Progress Toward Prescription.
    Bratcher A; Schlueter Wirtz S; Siegler AJ
    J Acquir Immune Defic Syndr; 2018 Aug; 78(4):e28-e30. PubMed ID: 29672350
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of healthcare providers in the roll out of preexposure prophylaxis.
    Krakower DS; Mayer KH
    Curr Opin HIV AIDS; 2016 Jan; 11(1):41-8. PubMed ID: 26417953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia.
    Sales JM; Cwiak C; Haddad LB; Phillips A; Powell L; Tamler I; Sheth AN
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):414-418. PubMed ID: 30985558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil.
    Jalil EM; Grinsztejn B; Velasque L; Ramos Makkeda A; Luz PM; Moreira RI; Kamel L; Fernandes NM; Ferreira ACG; Hoagland B; Wagner S; Liu A; McFarland W; Buchbinder S; Veloso VG; Wilson E;
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):445-452. PubMed ID: 30142140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
    HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preference for Condoms, Antiretroviral Preexposure Prophylaxis, or Both Methods to Reduce Risk for HIV Acquisition Among Uninfected US Black and Latino MSM.
    Mansergh G; Herbst JH; Mimiaga MJ; Holman J
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):e153-5. PubMed ID: 26302430
    [No Abstract]   [Full Text] [Related]  

  • 7. Brief Report: Integration of PrEP Services Into Routine Antenatal and Postnatal Care: Experiences From an Implementation Program in Western Kenya.
    Pintye J; Kinuthia J; Roberts DA; Wagner AD; Mugwanya K; Abuna F; Lagat H; Owiti G; Levin CE; Barnabas RV; Baeten JM; John-Stewart G
    J Acquir Immune Defic Syndr; 2018 Dec; 79(5):590-595. PubMed ID: 30204720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    Huang YA; Tao G; Samandari T; Hoover KW
    J Infect Dis; 2018 Jan; 217(4):617-621. PubMed ID: 29145597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System.
    Spinelli MA; Scott HM; Vittinghoff E; Liu AY; Morehead-Gee A; Gonzalez R; Gandhi M; Buchbinder SP
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):347-351. PubMed ID: 30085955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support Program.
    Siegler AJ; Mayer KH; Liu AY; Patel RR; Ahlschlager LM; Kraft CS; Fish R; Wiatrek SE; Sullivan PS
    Clin Infect Dis; 2019 Jan; 68(3):501-504. PubMed ID: 29982304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception.
    Delany-Moretlwe S; Mullick S; Eakle R; Rees H
    Curr Opin HIV AIDS; 2016 Jan; 11(1):87-93. PubMed ID: 26575146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care.
    Clement ME; Okeke NL; Munn T; Hunter M; Alexis K; Corneli A; Seña AC; McGee K; McKellar MS
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):e25-e27. PubMed ID: 29084043
    [No Abstract]   [Full Text] [Related]  

  • 13. Young adult women and correlates of potential adoption of pre-exposure prophylaxis (PrEP): results of a national survey.
    Rubtsova A; Wingood GM; Dunkle K; Camp C; DiClemente RJ
    Curr HIV Res; 2013 Oct; 11(7):543-8. PubMed ID: 24476352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
    Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
    Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
    Cowan FM; Delany-Moretlwe S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informal pre-exposure prophylaxis use in France: results from the Flash PrEP survey (2014).
    Rojas Castro D; Quatremere G; Sagaon-Teyssier L; Le Gall JM; Preau M; Suzan-Monti M; Spire B
    HIV Med; 2017 Apr; 18(4):308-310. PubMed ID: 27477336
    [No Abstract]   [Full Text] [Related]  

  • 17. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
    Volk JE; Marcus JL; Phengrasamy T; Blechinger D; Nguyen DP; Follansbee S; Hare CB
    Clin Infect Dis; 2015 Nov; 61(10):1601-3. PubMed ID: 26334052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.
    Jo Y; Bartholomew TS; Doblecki-Lewis S; Rodriguez A; Forrest DW; Tomita-Barber J; Oves J; Tookes HE
    PLoS One; 2020; 15(4):e0231424. PubMed ID: 32298320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.
    Kessler J; Myers JE; Nucifora KA; Mensah N; Toohey C; Khademi A; Cutler B; Braithwaite S
    AIDS; 2014 Nov; 28(18):2683-91. PubMed ID: 25493594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.